在线办公
期刊论坛
主 管
中国人民解放军总医院
主 办
中国人民解放军总医院老年心血管病研究所
中国科技出版传媒股份有限公司
编 辑
中华老年多器官疾病杂志编辑委员会
100853, 北京市复兴路28号
电话:010-66936756
传真:010-66936756
E-mail: zhlndqg@mode301.cn
创刊人 王士雯
总编辑 范利
副总编辑 陈韵岱
执行主编 叶大训
编辑部主任 王雪萍
ISSN 1671-5403
CN 11-4786
创刊时间 2002年
出版周期 月刊
邮发代号 82-408
友情链接
许可,王德燧,田丹.甲磺酸齐拉西酮对老年精神分裂症患者的临床疗效[J].中华老年多器官疾病杂志,2018,17(11):842~846
甲磺酸齐拉西酮对老年精神分裂症患者的临床疗效
Clinical evaluation of ziprasidone mesylate in the treatment of elderly patients with schizophrenia
投稿时间:2017-04-23  修订日期:2017-08-19
DOI:10.11915/j.issn.1671-5403.2018.11.193
中文关键词:  精神分裂症;急性激越症状;氟哌啶醇;甲磺酸齐拉西酮
英文关键词:schizophrenia; acute agitation symptoms; haloperidol; ziprasidone mesylate
基金项目:
作者单位E-mail
许可 四川省广元市精神卫生中心精神科, 广元 628000 3250926601@qq.com 
王德燧 四川省广元市精神卫生中心精神科, 广元 628000  
田丹 四川省广元市精神卫生中心精神科, 广元 628000  
摘要点击次数: 32
全文下载次数: 35
中文摘要:
      目的 探讨甲磺酸齐拉西酮治疗精神分裂症患者急性激越症状的临床效果。方法 选取2016年1月至2017年12月在四川省广元市精神卫生中心接受治疗的老年精神分裂症患者72例。采用随机数字表法将患者分为甲磺酸齐拉西酮组、氟哌啶醇组各36例。甲磺酸齐拉西酮组患者给予注射用甲磺酸齐拉西酮5~10 mg/次,肌内注射,每日总量不大于 20 mg;氟哌啶醇组患者给予常规氟哌啶醇针剂5 mg/次,肌内注射,每日总量不大于10 mg。记录并比较2组患者治疗前及治疗72 h的阳性和阴性症状量表(PANSS)、临床疗效总体印象量表之病情严重程度(CGI-SI)评分,以及治疗前(T0)和治疗后2 h(T1)、8 h(T2)、24 h(T3)、48 h(T4)、72 h(T5)阳性和阴性症状量表中的兴奋因子(PANSS-EC)评分。采用SAS 9.0软件进行统计分析。根据数据类型,组间比较采用独立样本t检验或χ2检验,治疗前后比较采用配对t检验。结果 治疗前及治疗72 h后的2组患者PANSS及CGI-SI评分比较,差异无统计学意义(P>0.05),治疗72 h后,2组患者PANSS及CGI-SI评分较治疗前均显著降低,差异有统计学意义(P<0.05)。治疗前、后各时间点2组患者PANSS-EC评分差异无统计学意义(P>0.05);与T0比较,T1-5各时间点2组患者PANSS-EC评分均显著降低,差异有统计学意义(P<0.05);与T1比较,T2-5各时间点2组患者PANSS-EC评分均显著降低,差异亦有统计学意义(P<0.05)。与氟哌啶醇组比较,甲磺酸齐拉西酮组患者肌强直[2.78%(1/36) vs 16.67%(6/36)]、震颤[2.78%(1/36) vs 19.44%(7/36)]、流涎[5.56%(2/36) vs 22.22%(8/36)]、头颈部运动[2.78%(1/36) vs 19.44%(7/36)]等副反应发生率显著降低,差异有统计学意义(P<0.05)。结论 甲磺酸齐拉西酮治疗精神分裂症急性激越症状患者的效果与常规氟哌啶醇相似,同时具有副作用发生率较低的优点。
英文摘要:
      Objective To investigate the clinical efficacy of ziprasidone mesylate in the treatment of acute exacerbation of schizophrenia. Methods Enrolled in this clinical study were 72 elderly patients with schizophrenia treated in the Department of Psychiatry of Sichuan Provincial Guangyuan Mental Health Center from January 2016 to December 2017, who were randomly divided into ziprasidone mesylate group and haloperidol group with 36 patients in each group. In the former, ziprasidone mesylate 5-10 mg once, no more than 20 mg every day was administered intramuscularly. In the latter, haloperidol 5 mg once, no more than 10 mg every day was administered intramuscularly. The two groups were compared in the positive and negative symptoms scale (PANSS) and clinical global impression-severity of illness (CGI-SI) before and up to 72 h after treatment, and positive and negative symptoms scale-excited component (PANSS-EC) before treatment (T0) and at 2 h (T1), 8 h (T2), 24 h (T3), 48 h (T4), and 72 h (T5) after treatment. SAS statistics 9.0 was used for statistical analysis. Depending on data type, independent sample t test or Chi-square test was used for intergroup comparison, and paired t test for comparison before and after treatment. Results There was no significant difference in PANSS and CGI-SI scores between the two groups before treatment and up to 72 h after treatment (P>0.05). PANSS and CGI-SI scores for two groups at 72 h after treatment were significantly lower than those before treatment (P<0.05). There was no significant difference in PANSS-EC scores between two groups at each time point before and after treatment (P<0.05). PANSS-EC scores at T1-5 were significantly lower than those at T0 (P<0.05), and PANSS-EC scores at T2-5 were significantly lower than those at T1, the differences being statistically significant (P<0.05). Compared with haloperidol group, the ziprasidone mesylate group had significantly lowerincidence of side effects, including myotonia [2.78%(1/36) vs 16.67%(6/36)], tremor [2.78%(1/36) vs 19.44%(7/36)], rogue [5.56%(2/36) vs 22.22%(8/36)], and head and neck movement [2.78%(1/36) vs 19.44%(7/36)], the differences being statistically significant (P<0.05). Conclusion Ziprasidone mesylate has similar efficacy in the treatment of acute agitation symptoms of schizophrenia compared with conventional haloperidol treatment and has low incidences of side effects.
查看全文    下载PDF阅读器
关闭